// App-Quantinova.ai

: Peptidylarginine Deiminase 4 Contributes to the Profibrotic Phenotype of Fibroblasts from Patients with Idiopathic Pulmonary Fibrosis and Promotes Experimental Pulmonary Fibrosis

Researchers

Presenter

  • A. J. Esposito

Principal Investigators

  • S. Chu

  • S. Poli De Frias

  • B. Sun

  • T. J. Doyle

  • S. Y. El-Chemaly

  • M. A. Perrella

  • I. Ho

  • K. Tsoyi

  • I. O. Rosas

Medical Centers

  • Pulmonary and Critical care medicine, Brigham and Womens Hospital, Boston, Massachusetts, United States

  • Division of Rheumatology, Immunology, and Allergy, Brigham & Women's Hospital, Boston, MA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Idiopathic pulmonary fibrosis

Biomarkers

  • N/A

Drug/Treatment

  • Bleomycin

  • DMSO

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved